TD Asset Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

TD Asset Management’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-36,990	Closed	-$2.21M	–	1427
2020 Q2	$2.21M	Buy	36,990 +1,600	+5%	+$98.8K	﹤0.01%	855
2020 Q1	$2.1M	Buy	35,390 +2,400	+7%	+$140K	﹤0.01%	824
2019 Q4	$1.81M	Buy	32,990 +3,872	+13%	+$145K	﹤0.01%	949
2019 Q3	$822K	Buy	29,118 +1,200	+4%	+$44K	﹤0.01%	1092
2019 Q2	$927K	Buy	27,918 +700	+3%	+$21.9K	﹤0.01%	1066
2019 Q1	$925K	Sell	27,218 -700	-3%	-$22.3K	﹤0.01%	1057
2018 Q4	$765K	Buy	27,918 +325	+1%	+$8.38K	﹤0.01%	1124
2018 Q3	$806K	Buy	+27,593	New	+$779K	﹤0.01%	1200

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

TD Asset Management's PRNB Position: Q3 2020 in Review

TD Asset Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 36,990 shares — an estimated $2.21M sold.

TD Asset Management first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $2.21M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

TD Asset Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
TD Asset Management sold 36,990 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2.21M.
TD Asset Management first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
TD Asset Management's Principia Biopharma Inc. Common Stock position peaked at $2.21M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on TD Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.